Safety and efficacy of first-line treatment with doxorubicin, cyclophosphamide, bortezomib, dexamethasone and lenalidomide (ACVDL) in newly diagnosed multiple myeloma patients of all ages. IMW 2015, PO-112

Kristian Thidemann Andersen, Maja Hinge, Erik Kay Segel, Tina Ormstrup, Paw Holdgaard, Henrik Boel-Jørgensen, Niels Pallisgaard, Gitte Birk Kerndrup, Torben Plesner

Publikation: Konferencebidrag uden forlag/tidsskriftPosterForskningpeer review

OriginalsprogEngelsk
Publikationsdatosep. 2015
StatusUdgivet - sep. 2015
Begivenhed15th International Myeloma Workshop (IMW) - Rome, Italien
Varighed: 23. sep. 201526. sep. 2015

Konference

Konference15th International Myeloma Workshop (IMW)
LandItalien
ByRome
Periode23/09/201526/09/2015

Citationsformater